The Rénarub network aims to track, on a national level, cases of rubella occurring during pregnancy and congenital rubella. It comprises clinical laboratories that test for anti-rubella IgM antibodies. In 2001, it comprised 272 laboratories, 37% of which were hospital-based and 63% private. In 2001, 38 cases met the case definitions. Among these 38 women, 6 gave birth to a child with congenital rubella syndrome (CRS), 2 had a spontaneous abortion, and 8 underwent an induced medical abortion (IMA). In one of the spontaneous abortions and one of the IMAs, the fetuses showed probable rubella-related malformations. Thus, the annual incidence of rubella infections during pregnancy recorded in metropolitan France by Rénarub in 2001 is 4.9 per 100,000 live births, and that of CRS is 0.78 per 100,000 live births. Even though the absolute number of identified CRMs remains low, their persistence today—particularly among multiparous women—seems difficult to accept in the French context, where an easily accessible, highly effective, and safe vaccine has been recommended for adolescents for nearly 30 years and has been actively promoted for infants for nearly 20 years. (R.A.)